Prognostic biomarkers for immunotherapy with ipilimumab in metastatic melanoma
Nyakas, M., Aamdal, E., Jacobsen, K. D., Guren, T. K., Aamdal, S., Hagene, K. T., Brunsvig, P., Yndestad, A., Halvorsen, B., Tasken, K. A., Aukrust, P., Mælandsmo, G. M., Ueland, T.
Published in Clinical and experimental immunology (01.07.2019)
Published in Clinical and experimental immunology (01.07.2019)
Get full text
Journal Article
Health-related quality of life in patients with advanced melanoma treated with ipilimumab: prognostic implications and changes during treatment
Aamdal, E., Skovlund, E., Jacobsen, K.D., Straume, O., Kersten, C., Herlofsen, O., Karlsen, J., Hussain, I., Amundsen, A., Dalhaug, A., Nyakas, M., Hagene, K.T., Holmsen, K., Aamdal, S., Kaasa, S., Guren, T.K., Kyte, J.A.
Published in ESMO open (01.10.2022)
Published in ESMO open (01.10.2022)
Get full text
Journal Article